Management of anxiety in the elderly: the balance between therapeutic and adverse effects.
D000368:Aged; D000700:Analgesics / Q000009:adverse effects; D014151:Anti-Anxiety Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000928:Antidepressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D001008:Anxiety Disorders / Q000139:chemically induced / Q000188:drug therapy* / Q000628:therapy; D001463:Barbiturates / Q000009:adverse effects / Q000378:metabolism; D001569:Benzodiazepines; D001702:Biopharmaceutics; D006331:Heart Diseases / Q000150:complications / Q000188:drug therapy; D006634:Histamine H1 Antagonists / Q000009:adverse effects; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy; D006993:Hypnotics and Sedatives / Q000009:adverse effects; D008171:Lung Diseases / Q000150:complications / Q000188:drug therapy; D008875:Middle Aged; D004366:Nonprescription Drugs / Q000009:adverse effects; D011409:Propylene Glycols / Q000009:adverse effects
D000700:Analgesics; D014151:Anti-Anxiety Agents; D000928:Antidepressive Agents; D001463:Barbiturates; D006634:Histamine H1 Antagonists; D006993:Hypnotics and Sedatives; D004366:Nonprescription Drugs; D011409:Propylene Glycols; D001569:Benzodiazepines